Clinical Trials

Showing trials with last updates posted in 2025.

NCT05935748 | TERMINATED | PHASE2
18 participants

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2023-07-28
Completion:
2025-06-30
Conditions
  • ccRCC
  • Clear Cell Renal Cell Carcinoma
  • Kidney Cancer
  • Kidney Neoplasms
  • Renal Cancer
  • Renal Neoplasms
  • Recurrent Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Refractory Renal Cell Carcinoma
  • Advanced Renal Cell Carcinoma
  • Carcinoma
  • Neoplasms
  • Carcinoma, Renal Cell
  • Neoplasms, Glandular and Epithelial
  • Neoplasm by Histology
  • Adenocarcinoma
  • Urologic Neoplasms
  • Urogenital Neoplasms
  • Neoplasms by Site
  • Kidney Diseases
  • Urologic Diseases
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT05256303 | COMPLETED | NA
160 participants

Rural Hospital-Level Care at Home for Acutely Ill Adults

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2022-02-16
Completion:
2023-12-17
Conditions
  • Infections
  • Heart Failure
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Gout Flare
  • Chronic Kidney Diseases
  • Hypertensive Urgency
  • Atrial Fibrillation Rapid
  • Anticoagulation
  • Diabetes and Its Complications
  • End of Life/Desires Only Medical Management
Interventions
  • OTHER
No Results Yet
NCT05119335 | TERMINATED | PHASE1/PHASE2
120 participants

A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2021-10-26
Completion:
2025-08-22
Conditions
  • ccRCC
  • Clear Cell Renal Cell Carcinoma
  • Kidney Cancer
  • Kidney Neoplasms
  • Renal Cancer
  • Renal Neoplasms
  • Recurrent Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Refractory Renal Cell Carcinoma
  • Advanced Renal Cell Carcinoma
  • Hypoxia
  • Renal Cell Carcinoma
  • Hypoxia Inducible Factor (HIF)
  • HIF2α Inhibitor
  • Hypoxia Inducible Factor 2 Alpha (HIF-2 Alpha)
  • Hypoxia Inducible Factor 2α (HIF-2α)
  • Clear Cell
Interventions
  • DRUG
No Results Yet
NCT04925453 | COMPLETED | NA
56 participants

tDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2021-01-19
Completion:
2025-06-30
Conditions
  • Brain Concussion
  • Brain Trauma
  • Attention Concentration Difficulty
  • Brain Injuries
  • Brain Injuries, Traumatic
  • Neurocognitive Dysfunction
  • Attention Impaired
  • Memory Impairment
  • Mild Traumatic Brain Injury
  • Mild Cognitive Impairment
Interventions
  • COMBINATION_PRODUCT
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page